Open AccessWillingness-to-Pay and Benefit–Cost Analysis of Botulinum Toxin for the Treatment of Rosacea in China: Findings from a Web-Based Survey
Author(s) -
Xizhao Yang,
Yuyan Ouyang,
Yuxuan Deng,
Yi Xiao,
Yan Tang,
Dan Jian,
Ji Li,
Hongfu Xie,
Yingxue Huang
Publication year - 2021
Publication title -
patient preference and adherence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 48
ISSN - 1177-889X
DOI - 10.2147/ppa.s311322
Subject(s) - rosacea , medicine , willingness to pay , logistic regression , china , dermatology , political science , law , economics , acne , microeconomics
Botulinum toxin (BTX) is a new treatment approach primarily aimed at relieving flushing and erythema for rosacea, but it is expensive and lacks economic benefit evaluation studies.This study aimed to investigate willingness-to-pay (WTP) of BTX treatment and conduct benefit-cost analysis (BCA) to assess if BTX treatment for rosacea is recommendable from a viewpoint of economics in China.